Literature DB >> 26523982

HPV-associated head and neck cancers in the Asia Pacific: A critical literature review & meta-analysis.

Mushfiq Hassan Shaikh1, Nigel A J McMillan2, Newell W Johnson3.   

Abstract

BACKGROUND: Malignancies of the upper aero-digestive tract are a major public health problem, especially in the Asia Pacific. Certain Human papillomaviruses (HPVs) are well-established risk factors for carcinoma of the uterine cervix and for a subset of head and neck carcinomata: however their true importance in different populations and anatomical subsites remains unclear. The major risk factors in Asia Pacific remain smoked/smokeless tobacco, areca nut, alcohol abuse and poor diet, with limited evidence for HPVs. We review published studies of association of HPV with anatomical site-specific Head & Neck Squamous Cell Carcinoma (HNSCC) in these populations and attempt a meta-analysis.
MATERIALS AND METHODS: From MEDLINE/PubMed/WEB-of SCIENCE/EMBASE/Scopus databases we found 67 relevant studies with a total of 7280 cases: 15 case-control studies met our inclusion criteria for meta-analysis, totaling 1106 cases & 638 controls. HPV detection rates, sample site and size, and methods of tissue preservation and HPV detection were tabulated for each study.
RESULTS: Studies were heterogeneous in terms of sample selection and method of detection of HPVs. Most were of limited quality. Averaging data from 67 studies of HNSCC, the prevalence of HPV of any subtype is approximately 36%. PCR (polymerase chain reaction) was the most used detection method and HPV16 the most common genotype reported. Meta-analyses of case-control studies from this region reveal significant heterogeneity but suggest higher HPV prevalence in oropharyngeal cancer (OR: 14.66; 95%CI: 6.09-35.26) compared to oral cavity cancer and laryngeal cancer; (OR: 4.06; 95%CI: 3.05-5.39 & OR: 3.23; 95%CI: 1.37-7.61) respectively.
CONCLUSION: In view of the significant association of HPV with HNSCC, studies with accurate subsite classification and more sensitive detection methods are necessary. Accurate data from this geographical region are essential to inform public health policies and treatment decisions, especially as studies from Europe and North America reveal HPV-driven cancers to be less aggressive, permitting treatment de-intensification.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Asia pacific populations; Head and neck squamous cell carcinoma; Human papillomavirus; Meta-analysis; Polymerase chain reaction (PCR)

Mesh:

Year:  2015        PMID: 26523982     DOI: 10.1016/j.canep.2015.09.013

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  22 in total

1.  Detection of Human Papillomavirus and p16INK4a Expression in Thai Patients with Oral Squamous Cell Carcinoma.

Authors:  Dulyapong Rungraungrayabkul; Naruemon Panpradit; Puangwan Lapthanasupkul; Nakarin Kitkumthorn; Poramaporn Klanrit; Ajiravudh Subarnbhesaj; Vanvisa Sresumatchai; Boworn Klongnoi; Siribang-On Piboonniyom Khovidhunkit
Journal:  Head Neck Pathol       Date:  2021-09-29

2.  Discrepancy in p16 expression in patients with HPV-associated head and neck squamous cell carcinoma in Thailand: clinical characteristics and survival outcomes.

Authors:  Lalida Arsa; Teerada Siripoon; Narumol Trachu; Sasithorn Foyhirun; Duangjai Pangpunyakulchai; Suda Sanpapant; Natini Jinawath; Poompis Pattaranutaporn; Artit Jinawath; Nuttapong Ngamphaiboon
Journal:  BMC Cancer       Date:  2021-05-06       Impact factor: 4.430

3.  Prevalence and types of high-risk human papillomaviruses in head and neck cancers from Bangladesh.

Authors:  Mushfiq H Shaikh; Aminul I Khan; Anwar Sadat; Ahmed H Chowdhury; Shahed A Jinnah; Vinod Gopalan; Alfred K Lam; Daniel T W Clarke; Nigel A J McMillan; Newell W Johnson
Journal:  BMC Cancer       Date:  2017-11-25       Impact factor: 4.430

4.  Molecular and serologic markers of HPV 16 infection are associated with local recurrence in patients with oral cavity squamous cell carcinoma.

Authors:  Chung-Guei Huang; Li-Ang Lee; Chun-Ta Liao; Tzu-Chen Yen; Shu-Li Yang; Yi-Chun Liu; Jung-Chin Li; Yu-Nong Gong; Chung-Jan Kang; Shiang-Fu Huang; Ku-Hao Fang; Kai-Ping Chang; Li-Yu Lee; Chuen Hsueh; Shin-Ru Shih; Kuo-Chien Tsao
Journal:  Oncotarget       Date:  2017-05-23

5.  Clinico-pathological features of oropharyngeal squamous cell carcinomas in Malaysia with reference to HPV infection.

Authors:  Lee Fah Yap; Sook Ling Lai; Anthony Rhodes; Hans Prakash Sathasivam; Maizaton Atmadini Abdullah; Kin-Choo Pua; Pathmanathan Rajadurai; Phaik-Leng Cheah; Selvam Thavaraj; Max Robinson; Ian C Paterson
Journal:  Infect Agent Cancer       Date:  2018-06-11       Impact factor: 2.965

Review 6.  Melatonin as a potential inhibitory agent in head and neck cancer.

Authors:  Chia-Ming Yeh; Shih-Chi Su; Chiao-Wen Lin; Wei-En Yang; Ming-Hsien Chien; Russel J Reiter; Shun-Fa Yang
Journal:  Oncotarget       Date:  2017-08-09

7.  Absence of human papillomavirus in oral cavity squamous cell carcinomas among Saudi patients.

Authors:  Louay Jaber; Hanadi Fatani; Saleh F Aldhahri
Journal:  Clin Exp Dent Res       Date:  2019-01-29

8.  Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience.

Authors:  Titaporn Nopmaneepaisarn; Napadon Tangjaturonrasme; Worawat Rawangban; Chanida Vinayanuwattikun; Somboon Keelawat; Andrey Bychkov
Journal:  BMC Cancer       Date:  2019-11-06       Impact factor: 4.430

9.  A simple and rapid diagnostic method for 13 types of high-risk human papillomavirus (HR-HPV) detection using CRISPR-Cas12a technology.

Authors:  Jiaojiao Gong; Guanghui Zhang; Wangguo Wang; Liping Liang; Qianyun Li; Menghao Liu; Liang Xue; Guanghui Tang
Journal:  Sci Rep       Date:  2021-06-17       Impact factor: 4.379

Review 10.  Emerging insights into recurrent and metastatic human papillomavirus-related oropharyngeal squamous cell carcinoma.

Authors:  Farhoud Faraji; David W Eisele; Carole Fakhry
Journal:  Laryngoscope Investig Otolaryngol       Date:  2017-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.